Exploring the gut microbiome of cancer patients to improve treatments
The unleashed microbiome of cancer patients as a discovery platform for rational microbiome engineering
This study is looking at how the bacteria in the gut of cancer patients change during treatment and how those changes might impact their health, with the hope of finding ways to improve cancer therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10886092 on NIH RePORTER |
What this research studies
This research investigates how the gut microbiome of cancer patients changes during treatment and how these changes can affect health outcomes. By collecting detailed data on both the microbiome and the patients' physiological responses, the researchers aim to identify specific microbial species that could be targeted to enhance treatment efficacy. Advanced machine learning techniques will be used to analyze this data, allowing for a better understanding of the interactions between medications and gut bacteria. The ultimate goal is to develop strategies for microbiome engineering that could lead to improved therapies for cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing treatment who are willing to participate in detailed microbiome analysis.
Not a fit: Patients who are not currently undergoing cancer treatment or those with stable, non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized microbiome-based therapies that enhance the effectiveness of cancer treatments.
How similar studies have performed: Previous research has shown promising results in understanding the microbiome's role in health, suggesting that this approach could yield significant insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Schluter, Jonas — New York University School of Medicine
- Study coordinator: Schluter, Jonas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.